CAR-T therapy: the role of the hematopoietic stem cell processing laboratory

Roberta Neri; Mauro PATRONE; Marco LADETTO; Lia Mele

CAR-T therapy: the role of the hematopoietic stem cell processing laboratory

Roberta Neri
, Mauro PATRONE
, Marco LADETTO
, Lia Mele

Risultato della ricerca: Capitolo in libro/report/atti di convegno › Contributo in volume (Capitolo o Saggio) › peer review

Abstract

Purpose of this paper is to review all the phases that in-volved, for the first time, the SC of Hematology and the SC of Transfu-sion Medicine, specifically, the CSE Processing laboratory, in imple-menting an innovative operative protocol of gene immunotherapydue to the inclusion of the first patient, affected by diffuse large B-celllymphoma (DLBCL), stage IV, into the CAR-T therapeutic program.The program took place within the SS Antonio e Biagio e Cesare Ar-rigo Hospital of Alessandria.

Titolo tradotto del contributo	[Machine translation] CAR-T therapy: the role of the hematopoietic stem cell processing laboratory
Lingua originale	Italian
Titolo della pubblicazione ospite	Working paper Vol.9 n.1
Editore	Working Paper of Public Health is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, on behalf of the Azienda Ospedaliera of Alessandria, Italy. ISSN 2279-9761
Numero di pagine	12
Volume	Vol. 9 (2022)
Stato di pubblicazione	Pubblicato - 2022

Accesso al documento

https://hdl.handle.net/11579/143399

Altri file e collegamenti

handle

Cita questo

Neri, R., PATRONE, M., LADETTO, M., & Mele, L. (2022). CAR-T therapy: the role of the hematopoietic stem cell processing laboratory. In Working paper Vol.9 n.1 (Vol. Vol. 9 (2022)). Working Paper of Public Health is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, on behalf of the Azienda Ospedaliera of Alessandria, Italy. ISSN 2279-9761. https://hdl.handle.net/11579/143399

@inbook{ce400ac000c043488a03f57eea9fd656,

title = "CAR-T therapy: the role of the hematopoietic stem cell processing laboratory",

abstract = "Purpose of this paper is to review all the phases that in-volved, for the first time, the SC of Hematology and the SC of Transfu-sion Medicine, specifically, the CSE Processing laboratory, in imple-menting an innovative operative protocol of gene immunotherapydue to the inclusion of the first patient, affected by diffuse large B-celllymphoma (DLBCL), stage IV, into the CAR-T therapeutic program.The program took place within the SS Antonio e Biagio e Cesare Ar-rigo Hospital of Alessandria.",

author = "Roberta Neri and Mauro PATRONE and Marco LADETTO and Lia Mele",

year = "2022",

language = "Italian",

volume = "Vol. 9 (2022)",

booktitle = "Working paper Vol.9 n.1",

publisher = "Working Paper of Public Health is an Open Access, peer-reviewed journal published by PAGEPress{\textregistered}, Pavia, on behalf of the Azienda Ospedaliera of Alessandria, Italy. ISSN 2279-9761",

}

Neri, R, PATRONE, M , LADETTO, M & Mele, L 2022, CAR-T therapy: the role of the hematopoietic stem cell processing laboratory. in Working paper Vol.9 n.1. vol. Vol. 9 (2022), Working Paper of Public Health is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, on behalf of the Azienda Ospedaliera of Alessandria, Italy. ISSN 2279-9761. <https://hdl.handle.net/11579/143399>

CAR-T therapy: the role of the hematopoietic stem cell processing laboratory. / Neri, Roberta; PATRONE, Mauro ; LADETTO, Marco et al.
Working paper Vol.9 n.1. Vol. Vol. 9 (2022) Working Paper of Public Health is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, on behalf of the Azienda Ospedaliera of Alessandria, Italy. ISSN 2279-9761, 2022.

Risultato della ricerca: Capitolo in libro/report/atti di convegno › Contributo in volume (Capitolo o Saggio) › peer review

TY - CHAP

T1 - CAR-T therapy: the role of the hematopoietic stem cell processing laboratory

AU - Neri, Roberta

AU - PATRONE, Mauro

AU - LADETTO, Marco

AU - Mele, Lia

PY - 2022

Y1 - 2022

N2 - Purpose of this paper is to review all the phases that in-volved, for the first time, the SC of Hematology and the SC of Transfu-sion Medicine, specifically, the CSE Processing laboratory, in imple-menting an innovative operative protocol of gene immunotherapydue to the inclusion of the first patient, affected by diffuse large B-celllymphoma (DLBCL), stage IV, into the CAR-T therapeutic program.The program took place within the SS Antonio e Biagio e Cesare Ar-rigo Hospital of Alessandria.

AB - Purpose of this paper is to review all the phases that in-volved, for the first time, the SC of Hematology and the SC of Transfu-sion Medicine, specifically, the CSE Processing laboratory, in imple-menting an innovative operative protocol of gene immunotherapydue to the inclusion of the first patient, affected by diffuse large B-celllymphoma (DLBCL), stage IV, into the CAR-T therapeutic program.The program took place within the SS Antonio e Biagio e Cesare Ar-rigo Hospital of Alessandria.

UR - https://iris.uniupo.it/handle/11579/143399

M3 - Contributo in volume (Capitolo o Saggio)

VL - Vol. 9 (2022)

BT - Working paper Vol.9 n.1

PB - Working Paper of Public Health is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, on behalf of the Azienda Ospedaliera of Alessandria, Italy. ISSN 2279-9761

ER -

CAR-T therapy: the role of the hematopoietic stem cell processing laboratory

Abstract

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo